Cholesterol Pathways

← Back to Cholesterol

Displaying pathways 1 – 24 of 105 in total

Bile Acid Biosynthesis
Bile Acid Biosynthesis
Steroid Biosynthesis
Steroid Biosynthesis
Steroidogenesis
Steroidogenesis
Cerebrotendinous Xanthomatosis (CTX)
Cerebrotendinous Xanthomatosis (CTX)
Cholesteryl ester storage disease
Cholesteryl ester storage disease
Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH
Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH
Hypercholesterolemia
Hypercholesterolemia
Zellweger Syndrome
Zellweger Syndrome
Steroid Biosynthesis
Steroid Biosynthesis
Smith-Lemli-Opitz Syndrome (SLOS)
Smith-Lemli-Opitz Syndrome (SLOS)
CHILD Syndrome
CHILD Syndrome
Desmosterolosis
Desmosterolosis
Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2)
Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2)
Lysosomal Acid Lipase Deficiency (Wolman Disease)
Lysosomal Acid Lipase Deficiency (Wolman Disease)
Ibandronate Action Pathway
Ibandronate Action Pathway
Simvastatin Action Pathway
Simvastatin Action Pathway
Pravastatin Action Pathway
Pravastatin Action Pathway
Rosuvastatin Action Pathway
Rosuvastatin Action Pathway
Alendronate Action Pathway
Alendronate Action Pathway
Steroidogenesis
Steroidogenesis
Bile Acid Biosynthesis
Bile Acid Biosynthesis
Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH
Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH
Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency
Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency

Displaying pathways 1 – 24 of 105 in total